/Investor DB

Colt Ventures

Crossover fund

Dallas · Seed–Growth · 3 people tracked

Find your way into Colt Ventures

177 people in our graph share verified history with the Colt Ventures team — schools, employers, funds. One of them is your warm intro.

Loren Asmusunlockedknows Brian Liu · together at Canterbury Consulting (overlapped)
×2knows the team · via Canterbury Consulting
×4knows the team · via Torrey Pines High School
×4knows the team · via University of California, Irvine - The Paul Merage School of Business
knows the team · via Morgan Stanley
✨ Fox Verdict
Sign up to see your fit

Investment thesis

Colt Ventures draws on decades of multi-sector investing experience, focusing on opportunities with meaningful, measurable impact. By staying targeted and narrow, the firm sources and evaluates hundreds of deals annually across private and public markets, leveraging a proprietary network of innovators, executives, and blue-chip investors. It invests up to $15M per deal, favoring inefficient markets, proven management teams, near-term value inflection points, and near-term liquidity horizons. Beyond direct private and public investments, Colt also allocates to institutional managers—hedge funds, venture capital, and private equity funds—aligned with its focus sectors and principles. The firm partners with portfolio companies to provide access to a differentiated network of industry experts.

Source: firm website, verified Sep 26, 2026.

Stage
Seed–Growth
Check
$15M
HQ
Dallas, TX, US
Instruments
Equity
Founded
2003
Tracked investments
8
Unicorns
1
IPOs
1

Team · 3 people

from the firm's website

What they invest in

from 1 of 8 portfolio companies

Biotech ×1Deep Tech ×1Digital Health ×1Medical Devices ×1

HQs:United States×1

Investments · 8 tracked

founders shown can be your intro path
Erascaerasca.comin𝕏NASDAQ: ERASApr 2020

Erasca is a clinical-stage oncology company developing therapies targeting RAS- and MAPK pathway-driven cancers using a modality-agnostic approach including small molecules, large molecules, and protein degraders.

BiotechDeep TechDigital HealthMedical DevicesSan Diego, US

Jonathan E. Lim, M.D.(Chairman, CEO and Co-founder)Gary Yeung, CFA(Chief Business Officer)in

BoardAlexander W. Casdin(Director)Pratik S. Multani, M.D.(Director)Valerie Harding-Start(Director)James A. Bristol, Ph.D.(Director)

Co-investorsAndreessen HorowitzARCH Venture PartnersEvolution VC PartnersFrazier Life SciencesLifeSci Venture PartnersCity Hill Ventures+1 more

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AlteromeARS PharmaBlack DiamondOdysseyProtosreataRocket

Exits · 1

1 IPOs

ErascaNASDAQ: ERAS

IPO stake values · per SEC filings

Value of this firm's stake in each portfolio company at its IPO price, from the prospectus principal-stockholder table.

CompanyOwnedIPO priceAt IPOStake value
Erasca5.5%$16.00Jul 2021$103.8M

Source: SEC S-1 / 424B prospectus filings. Stake value = shares beneficially owned × the initial public offering price, as disclosed — a market value at IPO, not a return multiple (the firm's original cost is not disclosed).

Frequently asked questions

How many investments has Colt Ventures made?
Colt Ventures has 8 tracked investments, 1 of which have exited.
What stage does Colt Ventures invest at?
Colt Ventures invests at the Seed, Series A, Series B, Series C, Growth stages.
What is Colt Ventures's typical check size?
Colt Ventures typically writes checks of $15M.
What sectors does Colt Ventures focus on?
Colt Ventures focuses on Biotech, Consumer, E-commerce, Energy, Fintech, New Materials, PropTech.
Where is Colt Ventures located?
Colt Ventures is headquartered in Dallas, US.
Who does Colt Ventures co-invest with?
Colt Ventures most often shares deals with Andreessen Horowitz, ARCH Venture Partners, Evolution VC Partners, among 6 tracked co-investors.

Similar investors

Featured in lists